The Proof with Simon Hill cover image

The Proof with Simon Hill

New heart disease test you should order | Thomas Dayspring, Md

Jul 1, 2024
Renowned lipidologist Dr. Thomas Dayspring discusses the significance of Lipoprotein(a) in cardiovascular health, genetic inheritance patterns, drug development strategies for reducing Lp(a) levels, and emerging treatments. Topics include oxidized phospholipids, statins, PCSK9 inhibitors, genetic variations, and lifestyle considerations.
02:20:42

Podcast summary created with Snipd AI

Quick takeaways

  • Understanding LP little a genetic inheritance and its impact on cardiovascular risk is crucial for personalized healthcare.
  • Measuring LP little a particle numbers is essential for accurate cardiovascular risk assessment, surpassing certain thresholds indicates high risk.

Deep dives

LP little a: An Inherited Risk Factor for Atherosclerosis and Valve Dysfunction

LP little a, a specific type of low-density lipoprotein (LDL), is found in about 20-25% of the global population. Genetically elevated levels of LP little a are linked to a higher risk of atherosclerosis and aortic valve dysfunction. Understanding the pathology and measurement of LP little a is crucial as elevated levels can indicate increased cardiovascular risk.

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner